Stay updated on TGRX-326 Chinese Phase I Clinical Trial
Sign up to get notified when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.

Latest updates to the TGRX-326 Chinese Phase I Clinical Trial page
- ChecktodayChange DetectedAdded a new revision entry: v3.5.5, replacing the previous v3.5.4 in the record history. This reflects an update to the page history rather than substantive content changes.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry, v3.5.4, has been added to the Study Record Versions, replacing the previous v3.5.3 in the history. This indicates an updated revision entry on the page reflecting a newer version of the study record.SummaryDifference0.1%

- Check43 days agoChange DetectedThis updates the displayed application/version revision for the ClinicalTrials.gov page from v3.5.2 to v3.5.3 without altering the study record’s content. The record history list of submissions remains the same.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check72 days agoChange DetectedSponsor entity updated from Shenzhen TargetRx, Inc. to Shenzhen TargetRx Co., Ltd.SummaryDifference0.2%

- Check79 days agoChange DetectedContacts/Locations and Sponsor/Collaborators sections were added; the record history shows revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.3%

Stay in the know with updates to TGRX-326 Chinese Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.